Latest News and Press Releases
Want to stay updated on the latest news?
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 5, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today provided an update on the regulatory and commercialization plans for GeneFx®...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 20, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that, effective September 19, 2013, MBI granted to certain directors and...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 30, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that the petition (the "Petition") filed by certain shareholders of MBI...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 29, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today reported its financial results for the six months ended June 30, 2013 (all amounts...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 22, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that MBI and its commercial partner, Precision Therapeutics, Inc., have...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 21, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that the petition (the "Petition") filed by certain shareholders of MBI...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 5, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that on June 4, 2013 certain shareholders of MBI served the company with a...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 3, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that its commercial partner, Precision Therapeutics, Inc., presented data...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 30, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today reported its financial results for the three months ended March 31, 2013 (all amounts...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 24, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that 2,318,000 warrants and agents' warrants to purchase an equal number of...